Armin Bruelisauer

553 total citations
10 papers, 474 citations indexed

About

Armin Bruelisauer is a scholar working on Oncology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Armin Bruelisauer has authored 10 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Armin Bruelisauer's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Virus-based gene therapy research (2 papers). Armin Bruelisauer is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Virus-based gene therapy research (2 papers). Armin Bruelisauer collaborates with scholars based in Switzerland, Spain and France. Armin Bruelisauer's co-authors include Michel Lemaire, Malcolm Rowland, Ryosei Kawai, Werner Niederberger, Jean‐Louis Steimer, Andrew Crowe, Hitoshi Sato, Caroline Gubser Keller, Albert Enz and Olivier Kretz and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.

In The Last Decade

Armin Bruelisauer

10 papers receiving 463 citations

Peers

Armin Bruelisauer

ONCOL

MB

SURGE

PHARM

PPCH

Pascal Espié Switzerland

Gleb Martovetsky United States

Isabelle Benz‐de Bretagne France

Shiyu Han China

Gilles‐Jacques Rivière Switzerland

Jeffrey D. Kearbey United States

Hisako Fujimura Japan

Jun Gu China

Mio Hirayama‐Kurogi Japan

Pascal Espié Switzerland

Armin Bruelisauer

92 ×0.7

ONCOL

106 ×0.9

MB

75 ×0.7

SURGE

84 ×1.0

PHARM

135 ×1.7

PPCH

Citations per year, relative to Armin Bruelisauer Armin Bruelisauer (= 1×) peers Pascal Espié

Countries citing papers authored by Armin Bruelisauer

Since Specialization

Citations

This map shows the geographic impact of Armin Bruelisauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Bruelisauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Bruelisauer more than expected).

Fields of papers citing papers by Armin Bruelisauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armin Bruelisauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Bruelisauer. The network helps show where Armin Bruelisauer may publish in the future.

Co-authorship network of co-authors of Armin Bruelisauer

This figure shows the co-authorship network connecting the top 25 collaborators of Armin Bruelisauer. A scholar is included among the top collaborators of Armin Bruelisauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armin Bruelisauer. Armin Bruelisauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

O’Reilly, Terence, Paul M.J. McSheehy, R. Kawai, et al.. (2009). Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents. Cancer Chemotherapy and Pharmacology. 65(4). 625–639. 55 indexed citations

2.

Keller, Caroline Gubser, Armin Bruelisauer, Michel Lemaire, & Albert Enz. (2002). Brain Pharmacokinetics of a Nonpeptidic Corticotropin-Releasing Factor Receptor Antagonist. Drug Metabolism and Disposition. 30(2). 173–176. 47 indexed citations

3.

Katopodis, Andreas, Richard G. Warner, Rudolf O. Duthaler, et al.. (2002). Removal of anti-Galα1,3Gal xenoantibodies with an injectable polymer. Journal of Clinical Investigation. 110(12). 1869–1877. 67 indexed citations

4.

Katopodis, Andreas, Richard G. Warner, Rudolf O. Duthaler, et al.. (2002). Removal of anti-Galα1,3Gal xenoantibodies with an injectable polymer. Journal of Clinical Investigation. 110(12). 1869–1877. 2 indexed citations

5.

Crowe, Andrew, et al.. (1999). Absorption and Intestinal Metabolism of SDZ-RAD and Rapamycin in Rats. Drug Metabolism and Disposition. 27(5). 627–632. 90 indexed citations

6.

Desrayaud, Sandrine, Elizabeth C. M. de Lange, Michel Lemaire, et al.. (1998). Effect of the Mdr1a P-Glycoprotein Gene Disruption on the Tissue Distribution of SDZ PSC 833, a Multidrug Resistance-Reversing Agent, in Mice. Journal of Pharmacology and Experimental Therapeutics. 285(2). 438–443. 16 indexed citations

7.

Lemaire, Michel, et al.. (1996). Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats. Cancer Chemotherapy and Pharmacology. 38(5). 481–486. 53 indexed citations

8.

Alonso, María J., et al.. (1995). Microdialysis Sampling to Determine the Pharmacokinetics of Unbound SDZ ICM 567 in Blood and Brain in Awake, Freely-Moving Rats. Pharmaceutical Research. 12(2). 291–294. 15 indexed citations

9.

Kawai, Ryosei, Michel Lemaire, Jean‐Louis Steimer, et al.. (1994). Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125. Journal of Pharmacokinetics and Biopharmaceutics. 22(5). 327–365. 123 indexed citations

10.

Bruelisauer, Armin, et al.. (1994). Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.. Drug Metabolism and Disposition. 22(2). 194–199. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact